Rutin
Bioflavonoids
- Drug class
- Bioflavonoids
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 3
Overview
Plain-language summary, compiled from the cited regulatory records
Rutin is a bioflavonoid [1]. It is approved for the temporary relief of symptoms associated with sinus or nasal congestion, hay fever, minor joint pain, or irritability stemming from sensitivity to phenolic compounds found in foods or other products [1].
In the past 12 months, there have been 3 adverse event reports associated with Rutin [2]. The most frequently reported adverse events include eye pain, abdominal discomfort, facial pain, fatigue, and headache [2].
This active ingredient is available under various brand names [N].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 8, 2026 |
USUnited States· FDA
1 product
Uses
INDICATIONS
*
How to take
Sources & citations
- [1]FDA DailyMed · 081a87ca-605c-4c… · revised January 8, 2026 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.